Business

Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30

RAHWAY, N.J., April 01, 2026--Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30

articleMerck & Company, Inc.April 1, 20263/company/merck-and-company-inc/news/merck-to-hold-first-quarter-2026-sales-and-earnings-conference-call-april-30
Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30

About this update from Merck & Company, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":217,"url":"https://media.zenfs.com/en/business-wire.com/e2b4bb393d4e92157f21905e26546388"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/AdbU27_.04XXRpxhYd0pyA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQzNA--/https://media.zenfs.com/en/business-wire.com/e2b4bb393d4e92157f21905e26546388","width":480,"height":217}},"lazy":false},{"type":"text","content":"RAHWAY, N.J., April 01, 2026--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2026 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, April 30. During the call, company executives will provide an overview of Merck’s performance for the quarter.","length":369,"tagName":"p"},{"type":"text","content":"Investors, journalists and the general public may access a live audio webcast of the call via this weblink. A replay of the webcast, along with the sales and earnings news release, supplemental financial disclosures and slides highlighting the results, will be available at www.merck.com.","length":288,"tagName":"p"},{"type":"text","content":"All participants may join the call by dialing (800) 369-3351 (U.S. and Canada Toll-Free) or (517) 308-9448 and using the access code 9818590.","length":141,"tagName":"p"},{"type":"text","content":"About MerckAt Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.","length":861,"tagName":"p"},{"type":"text","...

More updates from Merck & Company, Inc.

company executivesbiopharmaceutical companyinstitutional investorsMerckUnited States